Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Gasherbrum Bio, Inc., A Wholly Owned Subsidiary Of Structure Therapeutics

Clinical trials sponsored by Gasherbrum Bio, Inc., A Wholly Owned Subsidiary Of Structure Therapeutics, explained in plain language.

Trials to join now! 1 Not yet finished but already full! 3

Diabetes drug trial aims to shed pounds and control blood sugar

Disease control Recruiting now

This study is testing whether a new medication called aleniglipron is safe and helps with weight loss and blood sugar control in adults with type 2 diabetes who are overweight or have obesity. About 50 participants will take either the drug or a placebo (inactive pill) daily for …

Phase: PHASE2 • Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics • Aim: Disease control

Last updated Mar 31, 2026 12:11 UTC